X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
investigating or analysing materials by determining theirchemical or physical properties (21) 21
measuring (21) 21
physics (21) 21
testing (21) 21
beer (13) 13
biochemistry (13) 13
chemistry (13) 13
enzymology (13) 13
metallurgy (13) 13
microbiology (13) 13
mutation or genetic engineering (13) 13
spirits (13) 13
vinegar (13) 13
wine (13) 13
compositions thereof (12) 12
culture media (12) 12
microorganisms or enzymes (12) 12
propagating, preserving or maintaining microorganisms (12) 12
humans (9) 9
compositions or test papers therefor (8) 8
condition-responsive control in microbiological orenzymological processes (8) 8
index medicus (8) 8
measuring or testing processes involving enzymes, nucleicacids or microorganisms (8) 8
processes of preparing such compositions (8) 8
female (7) 7
adult (6) 6
organic chemistry (6) 6
peptides (6) 6
clinical neurology (5) 5
male (5) 5
middle aged (5) 5
multiple sclerosis (5) 5
antibodies, viral - blood (4) 4
leukoencephalopathy, progressive multifocal - chemically induced (4) 4
natalizumab (4) 4
neurosciences (4) 4
progressive multifocal leukoencephalopathy (4) 4
young adult (4) 4
abridged index medicus (3) 3
antibodies, monoclonal, humanized - adverse effects (3) 3
jc virus (3) 3
jc virus - immunology (3) 3
medicine, general & internal (3) 3
original research (3) 3
patients (3) 3
prevalence (3) 3
risk factors (3) 3
adolescent (2) 2
aged (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
care and treatment (2) 2
confidence intervals (2) 2
data bases (2) 2
gastroenterology and hepatology (2) 2
immunosuppressive agents (2) 2
immunosuppressive agents - therapeutic use (2) 2
leukoencephalopathy (2) 2
longitudinal studies (2) 2
multiple sclerosis - drug therapy (2) 2
multiple sclerosis, relapsing-remitting - drug therapy (2) 2
naltrexone (2) 2
natalizumab - adverse effects (2) 2
registries (2) 2
research (2) 2
research articles (2) 2
studies (2) 2
abortion, spontaneous - epidemiology (1) 1
age factors (1) 1
aids (1) 1
alcohol use (1) 1
alpha-4 integrin inhibitor (1) 1
antibodies (1) 1
article (1) 1
bezoars - diagnosis (1) 1
bezoars - etiology (1) 1
biological response modifiers (1) 1
biomarkers - blood (1) 1
biomedicine (1) 1
bk virus (1) 1
brain - pathology (1) 1
cancer (1) 1
cancer incidence (1) 1
causes of (1) 1
cellular and molecular neuroscience (1) 1
cerebrospinal-fluid (1) 1
child (1) 1
cholecystitis (1) 1
cholecystitis - epidemiology (1) 1
cholecystitis - surgery (1) 1
cholelithiasis - epidemiology (1) 1
cholelithiasis - surgery (1) 1
claims (1) 1
clinical trials (1) 1
cohort studies (1) 1
databases (1) 1
delayed-action preparations (1) 1
delivery (1) 1
deoxyribonucleic acid--dna (1) 1
dependence (1) 1
derivatives thereof (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (49) 49
French (9) 9
German (5) 5
Chinese (1) 1
Croatian (1) 1
Danish (1) 1
Korean (1) 1
Lithuanian (1) 1
Polish (1) 1
Serbian (1) 1
Slovenian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 20, pp. 1870 - 1880
Journal Article
Annals of Clinical and Translational Neurology, ISSN 2328-9503, 2014, Volume 1, Issue 10, pp. 755 - 764
Objective As of 3 September 2013, 399 cases of natalizumab‐associated progressive multifocal leukoencephalopathy (PML) were confirmed in multiple sclerosis... 
NEUROSCIENCES | CLINICAL NEUROLOGY | Nuclear magnetic resonance--NMR | Wheelchairs | Medical prognosis | Editorials | Family medical history | Patients | Deoxyribonucleic acid--DNA
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 9, p. 872
Journal Article
Drug Safety, ISSN 0114-5916, 10/2018, Volume 41, Issue 10, pp. 991 - 997
Here, we raise concerns regarding the methodology used and conclusions reached in a recent publication by Saucier et al. that retrospectively evaluated cases... 
Studies | Substance abuse treatment | Narcotics | Funding | Opioids | Dependence | Employees | Overdose | Drug overdose | Naltrexone | Drug dosages | Marketing
Journal Article
Annals of Neurology, ISSN 0364-5134, 08/2012, Volume 72, Issue 2, pp. 296 - 297
Journal Article
Annals of Neurology, ISSN 0364-5134, 08/2012, Volume 72, Issue 2, p. 296
Journal Article
Annals of Neurology, ISSN 0364-5134, 08/2012, Volume 72, Issue 2, pp. 296 - 297
Journal Article
Annals of Neurology, ISSN 0364-5134, 08/2012, Volume 72, Issue 2, pp. 296 - 297
Journal Article
Therapeutics and Clinical Risk Management, ISSN 1176-6336, 2012, Volume 8, pp. 313 - 321
Background: Intramuscular interferon beta-1a (IFN beta-1a), a multiple sclerosis (MS) therapy that has been commercially available for over a decade, provides... 
Intramuscular interferon beta-1a | Multiple sclerosis | Malignancy | Claims | Safety | Postmarketing surveillance | intramuscular interferon beta-1a | postmarketing surveillance | malignancy | multiple sclerosis | safety | CANCER INCIDENCE | HEALTH CARE SCIENCES & SERVICES | claims | FOLLOW-UP | Population | Statins | Data bases | Original Research
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.